<?xml version="1.0" encoding="UTF-8"?>
<ref id="pbi13194-bib-0022">
 <mixed-citation publication-type="journal" id="pbi13194-cit-0022">
  <string-name>
   <surname>Kam</surname>, 
   <given-names>Y.W.</given-names>
  </string-name>, 
  <string-name>
   <surname>Simarmata</surname>, 
   <given-names>D.</given-names>
  </string-name>, 
  <string-name>
   <surname>Chow</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Her</surname>, 
   <given-names>Z.</given-names>
  </string-name>, 
  <string-name>
   <surname>Teng</surname>, 
   <given-names>T.S.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ong</surname>, 
   <given-names>E.K.</given-names>
  </string-name>, 
  <string-name>
   <surname>Renia</surname>, 
   <given-names>L.</given-names>
  </string-name>
  <italic>et al</italic> (
  <year>2012</year>) 
  <article-title>Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long‐term clinical protection</article-title>. 
  <source xml:lang="en">J. Infect. Dis.</source>
  <volume>205</volume>, 
  <fpage>1147</fpage>–
  <lpage>1154</lpage>.
  <pub-id pub-id-type="pmid">22389226</pub-id>
 </mixed-citation>
</ref>
